Alpha-Klotho 20mg — Vial Spec, Reconstitution Math & COA

Overview of the Alpha-Klotho 20mg Research Vial Configuration

A 20mg vial of Alpha-Klotho contains a purified, lyophilized cake of recombinant soluble Klotho protein formulated strictly for laboratory research use. This high-mass yield format is designed for high-density assay platforms, multi-plate cell culture experiments, and longitudinal rodent studies where batch uniformity across multiple assay wells is critical. Ordering a 20mg mass fraction reduces lot-to-lot variability across extended experimental pipelines by providing a single, analytical-grade batch source.

In laboratory settings, research teams utilize the 20mg mass specification to construct stock solutions capable of supplying multiple working plates without requiring frequent reconstitution cycles. PX1 Research supplies high-purity research compounds synthesized under strict quality controls. If an exact 20mg size is temporarily out of stock or custom-synthesized for specialized institutional accounts, investigators can review standard catalog availability through our all-peptides inventory or reference individual product pages such as Alpha-Klotho for currently listed vial masses.

Regardless of the physical fill mass selected, all recombinant protein preparations require precise handling to preserve tertiary structural integrity and prevent biological activity loss caused by shearing, thermal exposure, or enzymatic contamination.

Reconstitution Mathematics: Volumetric Calculations for 20mg Vials

Reconstituting a 20mg lyophilized protein cake requires careful mathematical planning to achieve desired working concentrations (measured in mg/mL or µg/µL) while respecting vial displacement and solubility limits. The formula $C = \frac{m}{V}$ governs these calculations, where mass ($m$) is fixed at 20 mg, volume ($V$) is the added diluent, and concentration ($C$) is the resulting stock strength.

When introducing 1.0 mL of sterile diluent (such as Bacteriostatic Water or sterile 0.9% saline) into a 20mg vial, the resulting stock concentration is 20.0 mg/mL (or 20.0 µg/µL). This high-density working stock is optimal for micro-dosing bioassays or creating concentrated master mixes for cell culture media dilution.

Adding 2.0 mL of diluent yields a final concentration of 10.0 mg/mL (10.0 µg/µL). This concentration balances pipetting precision with volumetric volume, making it easy to aliquot 50 µL or 100 µL working samples into individual PCR tubes or cryovials. Reconstitution with 3.0 mL of diluent yields a final concentration of 6.67 mg/mL (6.67 µg/µL), suitable for protocols requiring larger fluid transfers without causing pipetting errors associated with ultra-low volumes.

Investigators calculating precise micro-additions across varying reconstitution volumes should utilize our online reconstitution calculator to eliminate manual conversion errors during assay setup.

Step-by-Step Reconstitution & Handling Protocols

To maintain protein stability during solvent addition, follow standardized aseptic laboratory protocols inside a certified laminar flow hood. Before inserting a needle or pipette tip, wipe the septum of the sealed glass vial with 70% isopropyl alcohol and allow it to air-dry completely.

Direct the stream of solvent down the interior glass wall of the vial rather than shooting it directly onto the lyophilized mass. Direct liquid impact can induce mechanical shearing of complex protein chains. Allow the diluent to gently soak into the cake at room temperature or on wet ice for 5–10 minutes.

Do not vortex high-molecular-weight proteins like Alpha-Klotho. Vortexing introduces air bubbles and surface-tension shear forces that lead to irreversible protein denaturation and aggregation. Instead, gently roll the vial between gloved palms or slowly invert the container 5–10 times until the lyophilized solid is completely dissolved into a clear, particle-free solution.

Aliquoting Protocols and Freezing Strategies

Repeated freeze-thaw cycles degrade recombinant protein structures through ice crystal formation, localized pH shifts, and aggregation. To maximize utility from a 20mg vial, researchers must immediately aliquot the reconstituted stock solution into single-use working volumes.

Using sterile, low-binding polypropylene microcentrifuge tubes or cryovials, divide the stock solution into volumes aligned with your daily assay demands (e.g., 50 µL to 200 µL aliquots). Low-binding plastics prevent nonspecific adsorption of the protein to the tube walls, ensuring consistent mass transfer.

Flash-freeze the aliquoted working stocks in liquid nitrogen or an ethanol/dry-ice bath prior to placing them into long-term sub-zero storage. Label each tube clearly with the compound name, lot number, concentration (mg/mL), and reconstitution date to ensure experimental traceability across the laboratory team.

Storage Specifications and Temperature Stability

Lyophilized Alpha-Klotho powder exhibits optimal stability when stored at -20°C to -80°C in a desiccated environment away from direct light exposure. Under these ideal conditions, unopened lyophilized vials remain stable up to expiration windows indicated on the Certificate of Analysis.

Once reconstituted into liquid solution, stock aliquots stored at 2°C to 8°C (refrigerated) should be utilized within 24 to 72 hours, depending on the buffer system and inclusion of preservative agents such as benzyl alcohol. Long-term storage of reconstituted working aliquots requires sub-zero temperatures at -80°C.

Avoid standard frost-free freezers for peptide and protein storage. Frost-free units utilize temperature auto-cycling to prevent frost build-up, which subjects frozen samples to damaging thermal oscillations. Utilize dedicated ultralow research freezers with continuous temperature monitoring systems.

Certificate of Analysis (COA) Verification and Quality Control

High-concentration research demands strict analytical validation to ensure experimental reproducibility. Every lot of Alpha-Klotho provided by PX1 Research undergoes rigorous testing in an ISO 17025 accredited laboratory to verify identity, purity, and safety profiles.

High-Performance Liquid Chromatography (HPLC) is employed to confirm chemical purity, ensuring target protein levels exceed 98%. Mass Spectrometry (MS) analysis verifies the exact molecular weight and amino acid sequence fidelity against theoretical reference structures.

Because 20mg vials are frequently deployed in cell culture and high-density bioassays, bacterial endotoxin testing via Chromogenic LAL (Limulus Amebocyte Lysate) assay is conducted on every batch to ensure endotoxin levels remain strictly below published threshold limits (< 0.1 EU/µg). Researchers can review or download specific batch reports through our centralized COA portal.

Selecting the Right Format: 20mg vs. Smaller or Larger Vials

Choosing between a 20mg vial and smaller formats (e.g., 2mg or 5mg vials) depends on the design, duration, and volume of your research project. A 20mg vial is optimal for laboratory teams running continuous automated assay pipelines or high-density cell-plating experiments where minimizing intra-assay stock variance is paramount.

Conversely, for short-term pilot studies, single-plate exploratory bioassays, or protocols where long-term sub-zero storage is unavailable, smaller 2mg or 5mg vial configurations may be more practical to prevent wasting unused reconstituted material.

For multi-center research initiatives or large-scale preclinical screening programs requiring custom fill sizes or bulk mass allocations beyond standard catalog offerings, institutional buyers can coordinate specialized procurement setups via our wholesale lab portal.

Comparative Analysis: Alpha-Klotho and Related Strength/Longevity Bio-active Peptides

In preclinical studies evaluating cellular senescence, mitochondrial bioenergetics, and neuromuscular integrity, researchers frequently examine Alpha-Klotho alongside other targeted regulatory research peptides. Selecting the appropriate research model depends on the underlying receptor pathways under investigation.

For instance, while Alpha-Klotho serves as an essential co-receptor for FGF23 signaling and modulates Wnt/β-catenin pathways, target compounds such as FOXO4-DRI are studied for their interactions with p53 signal transduction in senolytic research. Simultaneously, peptides like SS-31 target cardiolipin in the inner mitochondrial membrane to modulate reactive oxygen species (ROS) production, whereas mitochondrial-derived peptides like MOTS-c regulate metabolic homeostasis and AMPK activation pathways. Detailed mechanistic overviews of mitochondrial research peptides can be explored in our comprehensive MOTS-c guide.

Understanding these distinct pathways allows investigators to design robust comparative in vitro panels to evaluate skeletal muscle signaling, metabolic flux, and cellular stress responses.

Preclinical Mechanisms & Research Context

In vitro and animal model data indicate that Alpha-Klotho operates as a transmembrane protein and a circulating humoral factor involved in regulating phosphate homeostasis, oxidative stress pathways, and insulin/IGF-1 signaling cascades.

Preclinical studies suggest that recombinant soluble Klotho interacts with the FGF receptor complex to facilitate high-affinity binding of Fibroblast Growth Factor 23 (FGF23). Further cell culture models demonstrate that Klotho inhibits Wnt signaling activity, preventing downstream cellular senescence and fibrotic signaling responses in vascular and muscular tissues.

All data derived from these models remain within the domain of basic laboratory science. Alpha-Klotho is supplied strictly as a non-clinical research compound for laboratory evaluation, and no therapeutic, diagnostic, or clinical claims are made regarding human or animal application.